基于中位事件时间测试的单臂临床试验的两阶段适应性设计的样本大小的确定和评估
1Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, United States of America.
Contemporary clinical trials communications
|November 9, 2023
概括
这项研究增强了单臂II期临床试验的中位事件时间测试. 改进的方法为样本大小计算提供了明确的公式,优化了药物开发效率.
科学领域:
- 生物统计学 生物统计学
- 临床试验设计 临床试验设计
- 制药指标 (Pharmacometrics) 是一个指标.
背景情况:
- 临床试验对于药物开发至关重要,需要大量的时间和资源.
- 在II期疗效研究中,优先考虑时间到事件的终点,特别是中位生存时间.
- 传统的方法,如单样本日志等级测试,往往需要更大的样本大小.
研究的目的:
- 提高二阶段单臂II期临床试验中事件中位时间测试的计算效率.
- 在试验的两个阶段提供明确的公式来确定样本大小.
- 提出一种基于中位生存时间的增强测试程序来评估新的药物.
主要方法:
- 利用订单统计学的大样本理论进行精确的样本大小计算.
- 开发明确的公式来确定第一和第二阶段的样本大小.
- 实施基于中位事件时间测试的两阶段设计.
主要成果:
- 拟议的方法为样本大小计算提供了明确的公式,提高了效率.
- 增强的测试程序适用于单臂II期临床试验.
- 模拟和试验示例证明了改进方法的性能.
结论:
- 改进的中位事件时间测试为II期临床试验设计提供了更有效的方法.
- 明确的样本大小公式有助于在药物开发中更好地规划和分配资源.
- 这种方法通过优化使用时间到事件终点来支持新药的研究.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
200
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
200
Assumptions of Survival Analysis
136
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
136
Kaplan-Meier Approach
154
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
154
Introduction To Survival Analysis
250
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
250
Actuarial Approach
80
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
80
Censoring Survival Data
108
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
108


